ABI
Adamant Biomedical Investments Portfolio holdings
AUM
$418M
This Quarter Return
+10.95%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$418M
AUM Growth
+$418M
(+4.4%)
Cap. Flow
-$21.3M
Cap. Flow
% of AUM
-5.1%
Top 10 Holdings %
Top 10 Hldgs %
32.81%
Holding
108
New
12
Increased
10
Reduced
35
Closed
7
Top Buys
1 |
HSP
HOSPIRA INC
HSP
|
$5.51M |
2 |
Acadia Pharmaceuticals
ACAD
|
$5.4M |
3 |
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
|
$4.71M |
4 |
MDVN
MEDIVATION, INC.
MDVN
|
$4.48M |
5 |
Ligand Pharmaceuticals
LGND
|
$4.33M |
Top Sells
1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$5.12M |
2 |
ProShares Ultra NASDAQ Biotechnology
BIB
|
$4.39M |
3 |
Teva Pharmaceuticals
TEVA
|
$4.03M |
4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$3.82M |
5 |
QGENF
QIAGEN NV
QGENF
|
$3.53M |
Sector Composition
1 | Healthcare | 87.28% |
2 | Financials | 0.93% |
3 | Industrials | 0.35% |
4 | Technology | 0.06% |